CVS HEALTH Corp Insider Trading Activity
Every SEC Form 4 insider transaction reported for CVS HEALTH Corp (CVS), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are CVS insiders buying or selling?
In the last 12 months, CVS HEALTH Corp insiders reported 1 open-market purchase ($1.3K) and 2 sales ($323.7M) — net selling of $323.7M. Since February 2018, Trabud has recorded 83 Form 4 filings for CVS: 20 buys ($8.5M) and 63 sells ($822.2M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $1.3K by Steven H Nelson (EVP and President, Aetna) on Jan 27, 2026. SEC ↗
- The most recent open-market purchase was reported on Jan 27, 2026 (8 months ago).
Key Statistics (February 2018 – May 21, 2026)
Total Form 4 filings
83
SEC EDGAR
Insider filers
27
Insider buys (20)
$8.5M
Insider sells (63)
$822.2M
Insider sentiment
Net sellingNet insider flow of $813.7M in net selling since February 2018, and $323.7M in net selling over the last 12 months.
Recent CVS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | Larry Robbins | Director | Sale | 3.4M | $94.15 | $317.5M | SEC ↗ |
| May 11, 2026 | Tilak Mandadi | EVP, Chief Exp & Tech Officer | Sale | 69.6K | $89.58 | $6.2M | SEC ↗ |
| Jan 27, 2026 | Steven H Nelson | EVP and President, Aetna | Purchase | 24 | $53.70 | $1.3K | SEC ↗ |
| Oct 14, 2025 | Heidi B Capozzi | EVP and Chief People Officer | Purchase | 80 | $57.36 | $4.6K | SEC ↗ |
| Aug 29, 2025 | Anne A. Finucane | Director | Sale | 7.5K | $71.02 | $532.6K | SEC ↗ |
| Jun 9, 2025 | Guy P Sansone | Director | Purchase | 1.6K | $63.70 | $100.0K | SEC ↗ |
| May 6, 2025 | Larry Robbins | Director | Sale | 3.8M | $67.65 | $253.7M | SEC ↗ |
| Mar 7, 2025 | James David Clark | SVP, Cont & Chief Acct Officer | Sale | 7.5K | $66.35 | $498.5K | SEC ↗ |
| Feb 19, 2025 | Michael F Mahoney | Director | Purchase | 30.0K | $66.70 | $2.0M | SEC ↗ |
| May 2, 2024 | Edward J Ludwig | Director | Purchase | 1.0K | $53.88 | $53.9K | SEC ↗ |
| May 2, 2024 | Michael F Mahoney | Director | Purchase | 9.2K | $54.49 | $500.3K | SEC ↗ |
| Feb 16, 2024 | Prem S Shah | EVP and Pres-Pharm, Consumer W | Sale | 29.5K | $76.95 | $2.3M | SEC ↗ |
| Nov 6, 2023 | Edward J Ludwig | Director | Purchase | 2.0K | $70.47 | $140.9K | SEC ↗ |
| May 5, 2023 | Karen S Lynch | President and CEO | Purchase | 14.0K | $69.75 | $976.6K | SEC ↗ |
| Dec 16, 2022 | Thomas M Moriarty | EVP & General Counsel | Sale | 137.5K | $98.36 | $13.5M | SEC ↗ |
| Aug 5, 2022 | Alan Lotvin | EVP&President-PharmacyServices | Sale | 143.4K | $98.94 | $14.2M | SEC ↗ |
| Aug 5, 2022 | Daniel P Finke | EVP/Pres, Health Care Benefits | Sale | 9.5K | $100.00 | $954.6K | SEC ↗ |
| Jun 30, 2022 | Thomas M Moriarty | EVP & General Counsel | Sale | 138.7K | $95.00 | $13.2M | SEC ↗ |
| Apr 12, 2022 | Prem S Shah | EVP and Co-President of Retail | Sale | 17.0K | $105.00 | $1.8M | SEC ↗ |
| Apr 6, 2022 | Daniel P Finke | EVP/Pres, Health Care Benefits | Sale | 61.3K | $100.12 | $6.1M | SEC ↗ |
| Mar 31, 2022 | Prem S Shah | EVP and Co-President of Retail | Sale | 5.3K | $104.70 | $559.7K | SEC ↗ |
| Mar 18, 2022 | Prem S Shah | EVP and Co-President of Retail | Sale | 4.6K | $106.65 | $493.1K | SEC ↗ |
| Mar 17, 2022 | Thomas M Moriarty | EVP & General Counsel | Sale | 51.4K | $105.00 | $5.4M | SEC ↗ |
| Feb 11, 2022 | Edward J Ludwig | Director | Purchase | 1.0K | $105.90 | $105.9K | SEC ↗ |
| Feb 4, 2022 | Troyen A Brennan | EVP and Chief Medical Officer | Sale | 47.9K | $110.00 | $5.3M | SEC ↗ |
Showing the 25 most recent of 83 Form 4 filings for CVS HEALTH Corp.
Most active CVS insiders
- Troyen A Brennan9 filings
- Edward J Ludwig7 filings
- James David Clark7 filings
- Thomas M Moriarty7 filings
- Alan Lotvin6 filings
Ask anything about CVS insider activity
Use Trabud's AI agent to query CVS HEALTH Corp's Form 4 history in plain English — "Show me CVS CEO purchases this year" or compare it against any other ticker.
Open the AI agentCVS insider trading FAQ
Are CVS HEALTH Corp insiders buying or selling?
In the last 12 months, CVS HEALTH Corp insiders reported 1 open-market purchase ($1.3K) and 2 sales ($323.7M) — net selling of $323.7M. Since February 2018, Trabud has recorded 83 Form 4 filings for CVS: 20 buys ($8.5M) and 63 sells ($822.2M). Over the full record that is net selling of $813.7M.
How many insiders trade CVS stock?
27 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CVS HEALTH Corp. The most recent filing was accepted on May 21, 2026.
Where does Trabud get CVS insider trading data?
All CVS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.